The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123670182 12367018 2 F 20071002 20160801 20160513 20160812 EXP US-BAYER-2016-087601 BAYER 52.00 YR A F Y 0.00000 20160812 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123670182 12367018 1 PS BETASERON INTERFERON BETA-1B 1 Subcutaneous 8 MIU, QOD Y 103471 8 MIU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION QOD
123670182 12367018 2 SS BETASERON INTERFERON BETA-1B 1 Subcutaneous 0.3 MG, QOD Y 103471 .3 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION QOD
123670182 12367018 3 C CALCIUM CALCIUM 1 Oral UNK, BID 0 BID
123670182 12367018 4 C VITAMIN D CHOLECALCIFEROL 1 Oral UNK, BID 0 BID
123670182 12367018 5 C VITAMIN D CHOLECALCIFEROL 1 Oral UNK, 4IW 0
123670182 12367018 6 C VITAMIN D CHOLECALCIFEROL 1 Oral 4 DF, OW 0 4 DF /wk
123670182 12367018 7 C NEURONTIN GABAPENTIN 1 Oral 1 DF, TID 0 1 DF TID
123670182 12367018 8 C PROZAC FLUOXETINE HYDROCHLORIDE 1 Oral UNK, HS 0 QD
123670182 12367018 9 C PROZAC FLUOXETINE HYDROCHLORIDE 1 Oral 1 DF, QHS 0 1 DF
123670182 12367018 10 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Nasal UNK, 160/4.5 BID 0 BID
123670182 12367018 11 C TRAZODONE TRAZODONE HYDROCHLORIDE 1 Oral 150 MG, ADD'L SIG ADD'L SIG BY MOUTH 0 150 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123670182 12367018 1 Multiple sclerosis
123670182 12367018 2 Multiple sclerosis

Outcome of event

Event ID CASEID OUTC COD
123670182 12367018 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123670182 12367018 Arthralgia
123670182 12367018 Ataxia
123670182 12367018 Chest discomfort
123670182 12367018 Choking
123670182 12367018 Dysmetria
123670182 12367018 Dysphagia
123670182 12367018 Facial pain
123670182 12367018 Fatigue
123670182 12367018 Hyperreflexia
123670182 12367018 Initial insomnia
123670182 12367018 Middle insomnia
123670182 12367018 Multiple sclerosis
123670182 12367018 Multiple sclerosis relapse
123670182 12367018 Muscular weakness
123670182 12367018 Musculoskeletal disorder
123670182 12367018 Neck pain
123670182 12367018 Nystagmus
123670182 12367018 Oesophageal spasm
123670182 12367018 Osteoarthritis
123670182 12367018 Pain
123670182 12367018 Pain in extremity
123670182 12367018 Paraesthesia
123670182 12367018 Rheumatoid arthritis
123670182 12367018 Rheumatoid factor increased
123670182 12367018 Sensory level
123670182 12367018 Spinal osteoarthritis
123670182 12367018 Spondylolysis
123670182 12367018 Tremor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123670182 12367018 1 20071019 20150201 0